Atlas Trials

Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease

Clinical trial NCT01703624 · COMPLETED

Trial details

NCT number
NCT01703624
Sponsor
Prosonix Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2013-05-01
Primary completion
2013-08-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.